Galectin Therapeutics Inc.
USD2.42
-0.19 (-7.28%)
CEO
Joel Lewis
IPO Date
2002-09-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.60
Prev. Close
$2.61
Day Low
$2.40
Day High
$2.63
52W Low
$1.27
52W High
$7.13
Market Cap
$0.16B
Volume
0.28M
| 568 |
| $3.10 |
| 28 May 2026 | Jamil Khurram | Chief Medical Officer | M-Exempt | Disposed | 568 | $1.23 |
| 17 Mar 2026 | Brem Henry | director | A-Award | Acquired | 60,000 | $3.16 |
| 17 Mar 2026 | Brem Henry | director | Disposed | 0 | $0.00 |
| 9 Feb 2026 | ELDRED KARY | director | P-Purchase | Acquired | 300 | $2.70 |
| 22 Jan 2026 | LEWIS JOEL | director, officer: President and CEO | A-Award | Acquired | 91,000 | $3.04 |
| 21 Jan 2026 | CARSON BENJAMIN SR | director | A-Award | Acquired | 60,000 | $3.04 |
| 21 Jan 2026 | Zordani Richard A. Jr. | director | A-Award | Acquired | 60,000 | $3.04 |
| 21 Jan 2026 | Jamil Khurram | Chief Medical Officer | A-Award | Acquired | 65,000 | $3.04 |